Lindsey M. Kornowske

Lindsey M. Kornowske

Auto-generated profile, based on publicly available information

Lindsey M. Kornowske

Providence Medical Research Center, Providence Inland Northwest Health, Spokane, WA, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2026 in Kidney360
Verified
Journal Article
Open access
SWSusan P.Y. Wong
Susan P.Y. Wong
LKLindsey M. Kornowske
Lindsey M. Kornowske
CJCami R. Jones
Cami R. Jones
CRChristina L. Reynolds
Christina L. Reynolds
RLRyan Laundry
Ryan Laundry
KTKatherine R. Tuttle
Katherine R. Tuttle
Key Points: Approximately 6% of patients approaching kidney failure forgo dialysis, a proportion that has remained unchanged over the recent decade. Treatment with dialysis is more common in the United States than in other developed countries and even in not-for-profit US health systems. There is need to develop services, and the nephrology workforce to ensure conservative management is a viable treatment option. Background: After decades of rise, dialysis initiation rates are now declining. In parallel, conservative kidney management has emerged as an important therapeutic alternative to dialysis. However, contemporary trends in patients opting to forgo dialysis are poorly understood. Methods: This retrospective cohort study included adults with advanced kidney disease as defined by ≥2 outpatient measures of eGFR ≤15 ml/min per 1.73 m 2 for ≥90 days, who were receiving care in a large US health system between 2012 and 2020. Patients were followed through death or December 31, 2022. Administrative codes were used to identify patients who received KRT during follow-up. For remaining patients, documentation in their clinical progress notes was reviewed to determine the KRT decision made closest to the end of follow-up. Descriptive analyses evaluated trends in the distribution of treatment decisions made in 3-year periods (2012–2014, 2015–2017, and 2018–2020) and stratified by age group (<65, 65–74, 75–85, and ≥85 years). Results: Among the 12,678 patients in the cohort (age 66±15 years, 49% non-Hispanic White, 52% male), 90% received KRT on the basis of either administrative codes or chart documentation, 4% had been discussing and/or preparing for KRT, and 6% decided against KRT over a median follow-up of 3 (1–5) years. The distribution of KRT decisions did not meaningfully change over time. The proportion of patients in 2012–2014, 2015–2017, and 2018–2020 who went on to be treated with KRT was 90%, 91%, and 90%, respectively. Across the same periods, 7%, 6%, and 6% of patients had forgone KRT, respectively. The distribution of KRT decisions remained stable for all age groups over time. Conclusions: Forgoing KRT is uncommon. Over the recent decade, most patients approaching kidney failure receive or are preparing to receive KRT, underscoring its continued use as a default approach to kidney failure care.

23 June 2026 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
AZAnna Zemke
Anna Zemke
KMKiara Mayhand
Kiara Mayhand
RARZ Alicic
RZ Alicic
LKLindsey M. Kornowske
Lindsey M. Kornowske
CJCami R. Jones
Cami R. Jones
KTKatherine R. Tuttle
Katherine R. Tuttle
Background: Chronic kidney disease (CKD) and diabetes disproportionately affect the American Indian or Alaska Native population but understanding of major adverse kidney events (MAKE) in this population is limited. Methods: Electronic health records from the Providence health system identified the American Indian or Alaska Native adult population with diabetes during 2013-2022. A one-year window surrounding diabetes cohort entry was used to collect baseline data. Kaplan-Meier analyses assessed MAKE (≥40% estimated glomerular filtration rate [eGFR] decline, eGFR <15 mL/min/1.73 m 2 , dialysis or kidney transplant, and all-cause death) with propensity score matching (1:3) of American Indian or Alaska Native people to reference individuals (non-Hispanic White) by demographics and clinical characteristics. Cox proportional hazards modeling estimated associations between demographic, clinical, social, and healthcare utilization variables and MAKE. Results: The American Indian or Alaska Native population (N=6,103) was younger (mean±standard deviation age 54±15 years) with higher HbA1c (mean 7.4±2.2 mg/dL) compared to the reference population (N=354,283; age 62±14 years; HbA1c 6.9%±1.8%). During a median follow-up of 4.1 (interquartile range 2.0-6.4) years, the American Indian or Alaska Native population experienced a higher frequency of MAKE (26%, n=1,614) than the reference population (24%, n=85,920). With propensity score matching, MAKE survival estimates were significantly lower in the American Indian or Alaska Native population (p <0.0001). In the adjusted Cox model, increased MAKE risk was observed for the American Indian or Alaska Native population (versus reference population, hazard ratio [HR] 1.20, 95% confidence interval [CI] 1.15-1.27), higher social vulnerability index (HR 1.05, 95% CI 1.05-1.05), and hospitalization (HR 1.98, 95% CI 1.95-2.01), while more primary care visits were associated with lower MAKE risk (HR 0.78, 95% CI 0.77-0.79). Conclusion: The risk of MAKE was significantly increased in the American Indian or Alaska Native population with diabetes. Social factors and healthcare utilization importantly contributed to risk prediction for MAKE.

24 July 2025 in American Journal of Nephrology
Verified
Journal Article
Closed access
SMSiddharth S. Madapoosi
Siddharth S. Madapoosi
LKLindsey M. Kornowske
Lindsey M. Kornowske
KDKenn B. Daratha
Kenn B. Daratha
CRChristina L. Reynolds
Christina L. Reynolds
CJCami R. Jones
Cami R. Jones
LMLaura H. Mariani
Laura H. Mariani
Introduction: Obesity is associated with chronic kidney disease (CKD) incidence and progression. We examined whether bariatric surgery is associated with change in eGFR trajectory among patients with and without CKD. Methods: Patients who underwent bariatric surgery at two health systems were identified using ICD-9/ICD-10 and CPT codes. Linear mixed models were fit on estimated glomerular filtration rate (eGFR) trajectory pre- and post-surgery among patients with or without CKD. Models were adjusted for age, sex, race, ethnicity, body mass index, hypertension, diabetes, follow-up duration, and type of bariatric surgery. Post-surgery, eGFR trajectory among patients with CKD was also compared following 1:2 propensity score matching to (1) patients without CKD who underwent surgery and (2) patients with CKD who did not undergo surgery. Results: Patients with CKD (n = 139) at Michigan Medicine had a slower annual rate of eGFR decline post-surgery compared to patients without CKD (n = 278) (1.54 [−2.26, −0.81] vs. 3.15 [−3.41, −2.87] mL/min/1.73 m2; p < 0.001), despite adjusting for degree of weight loss. Among patients with CKD, surgery was associated with a slower annual rate of eGFR decline (−0.20 [−0.83, 0.43] post-surgery vs. −1.11 [−1.37, −0.85] mL/min/1.73 m2 for non-surgery patients; p < 0.001). In an external validation study of patients with CKD in the Providence health system, bariatric surgery predicted an average increase in annualized eGFR slope by 1.19 [0.12, 2.25] mL/min/1.73 m2 (p = 0.03). Conclusion: Bariatric surgery is associated with less eGFR decline and may have weight-independent effects on preserving kidney function among persons living with obesity and CKD.